Home
About
Publications Trends
Recent Publications
Expert Search
Archive
d dimer
Are There Limitations to Using D-Dimer in Cancer Patients?
While D-dimer is a useful marker, it is not specific to cancer-related conditions and can be elevated in various other scenarios, such as:
-
Inflammatory Diseases
-
Infections
-
Recent Surgery or Trauma
-
Pregnancy
Therefore, elevated D-dimer levels should be interpreted in conjunction with other clinical findings and diagnostic tests to avoid misdiagnosis.
Frequently asked queries:
What is D-Dimer?
Why is D-Dimer Important in Cancer?
How is D-Dimer Level Measured?
Can D-Dimer be Used for Cancer Prognosis?
How is D-Dimer Related to Cancer Treatment?
Are There Limitations to Using D-Dimer in Cancer Patients?
What are the Challenges in Cancer Therapy?
How Can Targeting Fat Metabolism Be a Potential Cancer Therapy?
What Does the Future Hold for Heparin in Cancer Treatment?
How Does Cancer Develop at the Molecular Level?
What is the Role of fMRI in Brain Tumor Management?
What Information is Collected?
What Are Some Techniques to Handle Class Imbalance?
What is the Impact of Treatment Response Variability?
How is Hoarseness Diagnosed in the Context of Cancer?
What Are the Symptoms of CRCI?
What Role Does the Microbiome Play in Cancer?
What is Prolongation of Survival in Cancer?
What Are the Potential Benefits and Risks?
Are There Risks Associated with Taking Vitamins for Cancer Patients?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe